These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 33389658

  • 1. Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima.
    Fujimura K, Sugiyama A, Akita T, Ohisa M, Nagashima S, Katayama K, Maeda R, Tanaka J.
    Int J Hematol; 2021 Apr; 113(4):576-585. PubMed ID: 33389658
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M, Tomonaga M.
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal gammopathy of undetermined significance in atomic bomb survivors: incidence and transformation to multiple myeloma.
    Neriishi K, Nakashima E, Suzuki G.
    Br J Haematol; 2003 May; 121(3):405-10. PubMed ID: 12716362
    [Abstract] [Full Text] [Related]

  • 4. Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster.
    Landgren O, Zeig-Owens R, Giricz O, Goldfarb D, Murata K, Thoren K, Ramanathan L, Hultcrantz M, Dogan A, Nwankwo G, Steidl U, Pradhan K, Hall CB, Cohen HW, Jaber N, Schwartz T, Crowley L, Crane M, Irby S, Webber MP, Verma A, Prezant DJ.
    JAMA Oncol; 2018 Jun 01; 4(6):821-827. PubMed ID: 29710195
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.
    Am J Nephrol; 2012 Jun 01; 35(4):365-71. PubMed ID: 22473253
    [Abstract] [Full Text] [Related]

  • 6. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE, Turesson I, Lund SH, Lindqvist EK, Mailankody S, Korde N, Björkholm M, Landgren O, Kristinsson SY.
    JAMA Oncol; 2015 May 01; 1(2):168-74. PubMed ID: 26181017
    [Abstract] [Full Text] [Related]

  • 7. Active multiple myeloma suppresses and typically eliminates coexisting MGUS.
    Campbell JP, Heaney JLJ, Pandya S, Afzal Z, Kaiser M, Owen R, Child JA, Gregory W, Morgan GJ, Jackson GH, Bunce CM, Drayson MT.
    Br J Cancer; 2017 Sep 05; 117(6):835-839. PubMed ID: 28728165
    [Abstract] [Full Text] [Related]

  • 8. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E, Miravalles E, Bergón E, Miranda I, Bergón M.
    Clin Chem Lab Med; 2005 Sep 05; 43(1):32-7. PubMed ID: 15653439
    [Abstract] [Full Text] [Related]

  • 9. [Monoclonal gammopathy of uncertain significance (MGUS) and occupational risk factors: criteria to carry out the health surveillance].
    Taino G, Bordini L, Sarto C, Porro S, Chirico F, Oddone E, Imbriani M.
    G Ital Med Lav Ergon; 2019 Jul 05; 41(3):202-207. PubMed ID: 31242349
    [Abstract] [Full Text] [Related]

  • 10. [Monoclonal gammopathy of uncertain significance (MGUS) and ionizing radiation].
    Taino G, Buonocore C, Stanga A, Imbriani M.
    G Ital Med Lav Ergon; 2020 Dec 05; 42(4):292-297. PubMed ID: 33600657
    [Abstract] [Full Text] [Related]

  • 11. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
    Murray D, Kumar SK, Kyle RA, Dispenzieri A, Dasari S, Larson DR, Vachon C, Cerhan JR, Rajkumar SV.
    Blood Cancer J; 2019 Dec 13; 9(12):102. PubMed ID: 31836698
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA, Rajkumar SV.
    Br J Haematol; 2007 Dec 13; 139(5):730-43. PubMed ID: 18021088
    [Abstract] [Full Text] [Related]

  • 13. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A, Czarkowska-Paczek B.
    Przegl Lek; 2012 Dec 13; 69(5):194-6. PubMed ID: 23050415
    [Abstract] [Full Text] [Related]

  • 14. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
    Landgren O, Shim YK, Michalek J, Costello R, Burton D, Ketchum N, Calvo KR, Caporaso N, Raveche E, Middleton D, Marti G, Vogt RF.
    JAMA Oncol; 2015 Nov 13; 1(8):1061-8. PubMed ID: 26335650
    [Abstract] [Full Text] [Related]

  • 15. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.
    Wadhera RK, Kyle RA, Larson DR, Dispenzieri A, Kumar S, Lazarus HM, Rajkumar SV.
    Blood; 2011 Sep 15; 118(11):2985-7. PubMed ID: 21765020
    [Abstract] [Full Text] [Related]

  • 16. Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors.
    Iwanaga M, Tagawa M, Tsukasaki K, Matsuo T, Yokota K, Miyazaki Y, Fukushima T, Hata T, Imaizumi Y, Imanishi D, Taguchi J, Momita S, Kamihira S, Tomonaga M.
    Blood; 2009 Feb 19; 113(8):1639-50. PubMed ID: 18849487
    [Abstract] [Full Text] [Related]

  • 17. Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
    Kyle RA, Rajkumar SV.
    Oncology (Williston Park); 2011 Jun 19; 25(7):578-86. PubMed ID: 21888255
    [Abstract] [Full Text] [Related]

  • 18. MGUS and smoldering myeloma: the most prevalent of plasma cell dyscrasias.
    Richardson PG, Laubach J, Mitsiades CS, Schlossman RL, Ghobrial IM, Munshi NC, Anderson KC.
    Oncology (Williston Park); 2011 Jun 19; 25(7):594, 596. PubMed ID: 21888257
    [No Abstract] [Full Text] [Related]

  • 19. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
    Chang SH, Gumbel J, Luo S, Thomas TS, Sanfilippo KM, Luo J, Colditz GA, Carson KR.
    Cancer Epidemiol Biomarkers Prev; 2019 Dec 19; 28(12):2055-2061. PubMed ID: 31501149
    [Abstract] [Full Text] [Related]

  • 20. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
    Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA.
    Ann Hematol; 2002 Jul 19; 81(7):357-61. PubMed ID: 12185503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.